Voloridge Investment Management
LUNG icon

Voloridge Investment Management’s Pulmonx LUNG Stock Holding History

Voloridge Investment Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-105,540
Closed -$1.76M – 1549
2022
Q3 		$1.76M Buy
105,540
+55,332
+110% +$1.02M 0.01% 1019
2022
Q2 		$739K Buy
+50,208
New +$1.03M ﹤0.01% 1255
2021
Q4 		– Sell
-83,412
Closed -$3M – 1724
2021
Q3 		$3M Buy
83,412
+16,632
+25% +$654K 0.02% 894
2021
Q2 		$2.95M Buy
+66,780
New +$2.91M 0.02% 841

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

Voloridge Investment Management's LUNG Position: Q4 2022 in Review

Voloridge Investment Management sold out of Pulmonx (LUNG) in Q4 2022, closing a stake of 105,540 shares — an estimated $1.76M sold.

Voloridge Investment Management first reported a position in LUNG in Q2 2021 and held it in 4 quarters. The position peaked at $3M in Q3 2021. 116 funds tracked by Wall St. Rank hold LUNG as of Q4 2022.

  • Voloridge Investment Management reported no remaining Pulmonx position as of Q4 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 105,540 Pulmonx shares in Q4 2022, an estimated $1.76M.
  • Voloridge Investment Management first reported a position in Pulmonx in Q2 2021 and held it in 4 quarters.
  • Voloridge Investment Management's Pulmonx position peaked at $3M in Q3 2021.
  • 116 funds tracked by Wall St. Rank held Pulmonx as of Q4 2022.

Based on Voloridge Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.